EGA
DARE icon

Eagle Global Advisors’s Dare Bioscience DARE Stock Holding History

Eagle Global Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-87
Closed -$29K – 375
2015
Q4 		$29K Sell
87
-22
-20% -$9.13K ﹤0.01% 369
2015
Q3 		$48K Sell
109
-76
-41% -$38.2K ﹤0.01% 363
2015
Q2 		$102K Buy
+185
New +$127K ﹤0.01% 367

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Eagle Global Advisors's DARE Position: Q1 2016 in Review

Eagle Global Advisors sold out of Dare Bioscience (DARE) in Q1 2016, closing a stake of 87 shares — an estimated $29K sold.

Eagle Global Advisors first reported a position in DARE in Q2 2015 and held it in 3 quarters. The position peaked at $102K in Q2 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q1 2016.

  • Eagle Global Advisors reported no remaining Dare Bioscience position as of Q1 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 87 Dare Bioscience shares in Q1 2016, an estimated $29K.
  • Eagle Global Advisors first reported a position in Dare Bioscience in Q2 2015 and held it in 3 quarters.
  • Eagle Global Advisors's Dare Bioscience position peaked at $102K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2016.

Based on Eagle Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.